Since joining HGF in 2010, much of Daniel’s work has concerned the drafting and prosecuting of patent applications across a broad spectrum of chemical sciences, but particularly in the fields of pharmaceuticals, medicinal chemistry, organic chemistry, graphene and other 2D materials, chemical engineering, carbon capture, dyes, agrochemicals, and resins for use in 3D printers. Daniel also has experience in advising on freedom to operate issues.
Daniel has formulated complex IP strategies for several award winning UK pharmaceutical companies.
He has worked extensively with a number of UK Russell Group universities for whom he has provided patentability opinions and drafted and prosecuted to grant worldwide patent applications in a range of technically complex chemistry related subject matters.
University of Oxford
Organic Chemistry; University of Oxford
Managing Intellectual Property IP Stars 2021, comprising the highly recommended IP professionals, has now been published. HGF is delighted to have 14 European attorneys listed. IP STARS is the leading …Read article
Pharmaceutical and biotechnology patent applications also make top 10 most patented. Recent statistics published by the EPO show that a total of 14,295 European patent applications were filed in 2020 …Read article
The 2021 EPO Guidelines provide much needed guidance on how to protect antibodies in Europe. Biological drugs including therapeutic antibodies have become increasingly important to the pharmaceutical industry. The European …Read article
Opportunities for additional pharmaceutical product patent protection in Europe, based on the use of a drug to treat a patient exhibiting a biomarker indicative of drug response. Recent years have …Read article
Exploring the growth of patents for connected medical devices, and how best to protect them. The Internet of Things (IoT) is expected to change our lives by creating a connected …Read article
To waive, or not to waive, that is the question. The earliest identified date of a patient presenting with symptoms of a “novel coronavirus” in Wuhan, China is reported to …Read article
HGF in Europe and Knobbe Martens in the US are holding a joint webinar on 9th June. In this webinar we will explore considerations for implementing an effective strategy to …Event details
HGF Partner Dr Susan Keston and Senior Patent Attorney Dr Sofie McPherson will be presenting a webinar ‘How to capitalise on the 5G healthcare revolution’ on 25th May. This session will explore how 5G …Event details
If you would like to discuss how HGF could help you, contact one of our IP specialists.